Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Basal-like breast carcinoma: a phenotypically distinct entity.

Haupt B, Ro JY, Schwartz MR.

Arch Pathol Lab Med. 2010 Jan;134(1):130-3. doi: 10.1043/1543-2165-134.1.130. Review.

PMID:
20073617
2.

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.

Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G.

Hum Pathol. 2006 Sep;37(9):1217-26. Epub 2006 Jul 18.

PMID:
16938528
3.

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

Livasy CA, Karaca G, Nanda R, Tretiakova MS, Olopade OI, Moore DT, Perou CM.

Mod Pathol. 2006 Feb;19(2):264-71.

4.

Identification of a basal-like subtype of breast ductal carcinoma in situ.

Livasy CA, Perou CM, Karaca G, Cowan DW, Maia D, Jackson S, Tse CK, Nyante S, Millikan RC.

Hum Pathol. 2007 Feb;38(2):197-204.

PMID:
17234468
5.

Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.

Staaf J, Ringnér M, Vallon-Christersson J, Jönsson G, Bendahl PO, Holm K, Arason A, Gunnarsson H, Hegardt C, Agnarsson BA, Luts L, Grabau D, Fernö M, Malmström PO, Johannsson OT, Loman N, Barkardottir RB, Borg A.

J Clin Oncol. 2010 Apr 10;28(11):1813-20. doi: 10.1200/JCO.2009.22.8775. Epub 2010 Mar 15.

PMID:
20231686
6.

Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.

Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.

J Surg Res. 2007 Nov;143(1):109-18.

PMID:
17950079
7.
8.

Morphological characteristics of basal-like subtype of breast carcinoma with special reference to cytopathological features.

Ishihara A, Tsuda H, Kitagawa K, Yoneda M, Shiraishi T.

Breast Cancer. 2009;16(3):179-85. doi: 10.1007/s12282-009-0108-x. Epub 2009 May 23.

PMID:
19466513
9.

EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast.

Vranic S, Tawfik O, Palazzo J, Bilalovic N, Eyzaguirre E, Lee LM, Adegboyega P, Hagenkord J, Gatalica Z.

Mod Pathol. 2010 May;23(5):644-53. doi: 10.1038/modpathol.2010.50. Epub 2010 Mar 5.

10.

Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas).

Lerma E, Peiro G, Ramón T, Fernandez S, Martinez D, Pons C, Muñoz F, Sabate JM, Alonso C, Ojeda B, Prat J, Barnadas A.

Mod Pathol. 2007 Nov;20(11):1200-7. Epub 2007 Sep 21.

11.

Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome.

Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.

Ann Surg Oncol. 2007 Oct;14(10):2994-3003. Epub 2007 Jul 24.

PMID:
17647064
12.

Is 'basal-like' carcinoma of the breast a distinct clinicopathological entity? A critical review with cautionary notes.

Moinfar F.

Pathobiology. 2008;75(2):119-31. doi: 10.1159/000123850. Epub 2008 Jun 10. Review.

PMID:
18544967
13.

Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinicopathological characteristics, biological features and prognosis.

Del Casar JM, Martín A, García C, Corte MD, Alvarez A, Junquera S, González LO, Bongera M, García-Muñiz JL, Allende MT, Vizoso F.

Eur J Obstet Gynecol Reprod Biol. 2008 Dec;141(2):147-52. doi: 10.1016/j.ejogrb.2008.07.021. Epub 2008 Sep 2.

PMID:
18768247
14.

Increased insulin-like growth factor-1 receptor mRNA expression predicts poor survival in immunophenotypes of early breast carcinoma.

Peiró G, Adrover E, Sánchez-Tejada L, Lerma E, Planelles M, Sánchez-Payá J, Aranda FI, Giner D, Gutiérrez-Aviñó FJ.

Mod Pathol. 2011 Feb;24(2):201-8. doi: 10.1038/modpathol.2010.191. Epub 2010 Nov 5.

15.
16.

Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.

Collins LC, Martyniak A, Kandel MJ, Stadler ZK, Masciari S, Miron A, Richardson AL, Schnitt SJ, Garber JE.

Am J Surg Pathol. 2009 Jul;33(7):1093-7. doi: 10.1097/PAS.0b013e31819c1c93.

PMID:
19390427
17.

Expression of tight junction protein claudin-4 in basal-like breast carcinomas.

Kulka J, Szász AM, Németh Z, Madaras L, Schaff Z, Molnár IA, Tokés AM.

Pathol Oncol Res. 2009 Mar;15(1):59-64. doi: 10.1007/s12253-008-9089-x. Epub 2008 Aug 28.

PMID:
18752049
18.

Low methylation levels of the SFRP1 gene are associated with the basal-like subtype of breast cancer.

Jeong YJ, Jeong HY, Bong JG, Park SH, Oh HK.

Oncol Rep. 2013 May;29(5):1946-54. doi: 10.3892/or.2013.2335. Epub 2013 Mar 6.

PMID:
23467623
19.

[Morphological features of basal-like subtype invasive carcinoma of breast].

Gao LX, Yang GZ, Ding HY, Li L.

Zhonghua Bing Li Xue Za Zhi. 2008 Feb;37(2):83-7. Chinese.

PMID:
18681317
20.

Expression of basal and luminal cytokeratins in breast cancer and their correlation with clinicopathological prognostic variables.

Mohammadizadeh F, Naimi A, Rajabi P, Ghasemibasir H, Eftekhari A.

Indian J Med Sci. 2009 Apr;63(4):152-62. doi: 10.4103/0019-5359.50764.

PMID:
19414985

Supplemental Content

Support Center